News

Filter

Current filters:

Nplate

1 to 9 of 20 results

FDA eases REMS requirements for Amgen’s Nplate and GSK’s Promacta

07-12-2011

The US Food and Drug Administration says that an agency initiated review of the current information has…

AmgenBiotechnologyGlaxoSmithKlineNorth AmericaNplatePharmaceuticalPromactaRare diseasesRegulation

UK NICE gives final yes for Amgen’s Nplate but no for PharmaMar’s Yondelis

27-04-2011

There was mixed news this morning from the UK’s drug rationing body the National Institute for Health…

AmgenBiotechnologyCardio-vascularEuropeNplateOncologyPharmaceuticalPharmaMarRegulationYondelisZeltia

2010 Prix Galien winners include Merck & Co, Novartis, Amgen and Bayer

06-04-2011

Scholarly papers from the winners and finalists of the 2010 Prix Galien USA and Prix Galien International…

AmgenBayerBiotechnologyCoartemMerck & CoNovartisNplatePharmaceuticalResearchRotaTeqXarelto

UK’s NICE backs Merck & Co’s Simponi and Amgen’s Nplate

18-03-2011

By way of a change, there was good news yesterday from the UK’s drugs watchdog the National Institute…

AmgenAnti-Arthritics/RheumaticsEuropeImmunologicalsMerck & CoNplatePharmaceuticalPricingRegulationSimponi Injection

UK’s NICE recommends Amgen’s Nplate for idiopathic thrombocytopenic purpura

02-12-2010

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in preliminary draft…

AmgenBiotechnologyEuropeNplatePharmaceuticalPricingRare diseasesRegulation

Amgen's Nplate reduces number of splenectomies

08-06-2009

US biotechnology major Amgen's Nplate (romiplostim) significantly reduced the incidences of splenectomy…

AmgenNplateRomiplostim

1 to 9 of 20 results

COMPANY SPOTLIGHT

Menarini

Back to top